Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4/A Derivatives Options or other derivatives
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Open-market sale Chief Financial Officer sold 390 shares at $7.66 ($2,987)
  9. 4 Open-market sale President and CEO sold 778 shares at $7.66 ($5,959)
  10. 8-K Event Other events
  11. 424B5 Offering Prospectus
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Other events
  20. 8-K Event Regulation FD disclosure

Page 15 of 38 · 755 filings